rs1555365509
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PP2PP3_ModeratePP5
The NM_015915.5(ATL1):c.1024C>G(p.Pro342Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P342Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_015915.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 3AInheritance: AD, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- neuropathy, hereditary sensory, type 1DInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATL1 | NM_015915.5 | c.1024C>G | p.Pro342Ala | missense_variant | Exon 10 of 14 | ENST00000358385.12 | NP_056999.2 | |
| ATL1 | NM_001127713.1 | c.1024C>G | p.Pro342Ala | missense_variant | Exon 11 of 14 | NP_001121185.1 | ||
| ATL1 | NM_181598.4 | c.1024C>G | p.Pro342Ala | missense_variant | Exon 10 of 13 | NP_853629.2 | ||
| ATL1 | XM_047431430.1 | c.1024C>G | p.Pro342Ala | missense_variant | Exon 11 of 15 | XP_047287386.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 3A Pathogenic:1Uncertain:1
- -
Other missense substitutions at this codon (p.Pro342Gln and p.Pro342Ser) have been reported in individuals affected with hereditary spastic paraplegia (PMID: 23108492, 22552817). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with ATL1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with alanine at codon 342 of the ATL1 protein (p.Pro342Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at